BrainsWay (NASDAQ:BWAY) shares spiked on Tuesday after the U.S. FDA cleared an additional treatment protocol for the company’s Deep Transcranial Magnetic Stimulation system (Deep TMS), a therapy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results